Rare Tumors (Sep 2023)
Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
Abstract
No abstracts available.
Rare Tumors (Sep 2023)